25 results
ARS
2024 FY
CCCC
C4 Therapeutics, Inc.
30 Apr 24
Annual report to shareholders
8:52am
supplies. If our current or future suppliers, whether for raw materials, drug substance, or drug product, are unable to supply us with sufficient
ARS
znv7apau0ln3r5j
28 Apr 23
Annual report to shareholders
7:03am
424B4
6jli92srnktvu4
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
e8i5xg18hrlrgk2j2w
19 May 21
Draft registration statement
12:00am
10-K
y4e243afuugign5
11 Mar 21
Annual report
4:19pm